A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Community-acquired pneumonia (CAP) accounts for a major proportion of intensive care unit (ICU) admissions for respiratory failure and sepsis. Diagnostic uncertainty complicates case management, which may delay appropriate cause-specific treatment.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am. J. Respir. Crit. Care Med.

Title: American journal of respiratory and critical care medicine

ISSN (Electronic): 1535-4970

ISSN (Print): 1073-449X

Publication date (Electronic): Oct 1 2015

Volume: 192

Issue: 7

Affiliations

[1 ] 1 Center for Experimental Molecular Medicine and Center for Infection and Immunity Amsterdam.

[2 ] 2 Department of Intensive Care Medicine.

[3 ] 3 Department of Medical Microbiology, and.

[4 ] 4 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; and.

[5 ] 5 Clinical Epidemiology Biostatistics and Bioinformatics.

[6 ] 6 Cologne Center for Genomics.

[7 ] 7 Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, and.

[8 ] 8 Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.

[9 ] 9 Department of Intensive Care Medicine, and.

[10 ] 10 Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Article

DOI: 10.1164/rccm.201502-0355OC

PubMed ID: 26121490

SO-VID: 8259bbe0-5dd1-4e52-bb77-40e79fae4844

History

Keywords: biomarker,blood,microarray,pneumonia,sepsis

Data availability:

Keywords: biomarker, blood, microarray, pneumonia, sepsis

Comments

Comment on this article

scite_

Cited by 97

See all cited by

- Version 1